Drug Alert List for October 2023
A total of 1105 samples were tested by the CDSCO. Based on the samples tested, CDSCO has found a total of 61 drugs, medical devices and cosmetics that are identified as being deficient.
India and Netherlands Collaborate on Medical Product Regulation
India and Netherlands have formalized their commitment to enhance medical product regulation and elevate the quality of healthcare services through a Memorandum of Intent (MoI). The collaboration aims to foster cooperation in pharmaceutical and medical technology industries, a significant stride towards global health goals.
CDSCO invites Proposals for Development of Digital Drugs Regulatory System
The aim of this project is to develop the DDRS as a unified digital ecosystem that will replace existing portals. DDRS is envisioned to be a Single Window, Single Sign On, and Unified Portal for all regulatory activities in the field of pharmaceuticals. The development of DDRS represents a significant step towards enhancing regulatory systems in India, ensuring the availability of quality medicines for the country and the world.
CDSCO Grants Approval to Private Testing Laboratories to test Cough Syrups to be Exported
Central Drugs Standard Control Organisation (CDSCO) has granted approval to 3 NABL Accredited Private Testing Laboratories to test cough syrups to be exported by manufacturers and authorised persons of manufacturers/ exporters. This notice was issued on 13th September, 2023.
WHO Issues Alert Over Fake DEFITELIO Drug in India and Turkey
The WHO emphasizes the importance of purchasing medications only from reputable sources and urges healthcare providers to remain vigilant in verifying the authenticity of the products they prescribe and dispense. Patients should also take an active role in confirming the legitimacy of their medications to safeguard their health.
NPPA sets Retail Prices for 51 Formulations
The ceiling price for a pack of scheduled formulations should be determined by the concerned manufacturer in accordance with the ceiling price specified. Manufacturers are required to issue a price list in Form-V from the date of notification, as per the Drugs Price Control Order (DPCO), 2013, to the NPPA through IPDMS. A copy of the price list should also be submitted to the State Drug Controller and dealers.
CDSCO publishes List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality/Spurious for May 2023
This list includes a total of 28 drugs, medical devices and cosmetics that are identified as being deficient. Out of these 28 samples, 27 were declared as not of standard quality and 1 was declared spurious.
